Cat. No. | Product Name / Activity |
---|---|
3025 | AA 2414 |
Thromboxane A2 (TP) receptor antagonist | |
0671 | AH 6809 |
EP1 and EP2 receptor antagonist | |
5701 | AMG 853 |
Potent dual CRTH2 and prostaglandin D2 (PGD2) receptor antagonist | |
2732 | BAY-u 3405 |
Dual TP/DP2 (CRTH2) receptor antagonist | |
5327 | BGC 20-1531 hydrochloride |
High affinity and selective EP4 antagonist | |
6240 | DG 041 |
Potent and selective EP3 antagonist; antiplatelet and antithrombotic | |
5924 | ER 819762 |
Potent EP4 receptor antagonist; orally bioavailable | |
4668 | GW 627368 |
Selective EP4 receptor competitive antagonist | |
2514 | L-161,982 |
Selective EP4 receptor antagonist | |
1949 | L-670,596 |
Potent, selective thromboxane A2/prostaglandin endoperoxide antagonist | |
3342 | L-798,106 |
Potent and highly selective EP3 antagonist | |
5406 | ONO 8130 |
EP1 receptor antagonist | |
3565 | ONO AE3 208 |
High affinity and selective EP4 antagonist | |
4818 | PF 04418948 |
Potent and selective EP2 receptor antagonist | |
4268 | Ro 1138452 hydrochloride |
Selective prostacyclin IP receptor antagonist | |
5568 | S 18886 |
Potent thromboxane A2 (TP) antagonist | |
1206 | SC 19220 |
Selective EP1 receptor antagonist | |
3758 | SC 51089 |
Selective EP1 receptor antagonist | |
2791 | SC 51322 |
Potent EP1 receptor antagonist | |
5052 | TG 4-155 |
High affinity and selective EP2 receptor antagonist |